The psychological and emotional traumas experienced over a lifetime–such as the death of a loved one, divorce, natural disaster, house fire or car accident, physical or mental abuse—may contribute to adult irritable bowel syndrome (IBS), according to the results of a study unveiled today at the American College of Gastroenterology’s (ACG) 76th Annual Scientific meeting […]
For the first time, researchers at McMaster University have conclusive evidence that bacteria residing in the gut influence brain chemistry and behavior. The findings are important because several common types of gastrointestinal disease, including irritable bowel syndrome, are frequently associated with anxiety or depression. In addition, there has been speculation that some psychiatric disorders, such […]
Recognizing that gastrointestinal (GI) dysfunction affects many children and adolescents with autism spectrum disorders (ASD), Autism Speaks, the world’s largest autism science and advocacy organization, today announced a major Suzanne and Bob Wright Trailblazer Award for research into the biological mechanisms of GI disorders in ASD.
Physical activity improves symptoms in patients with IBS and is protective against symptom deterioration. This has recently been shown in a study from the University of Gothenburg, Sweden. The study is published in the American Journal of Gastroenterology and has attracted great attention in the United States, United Kingdom, and Sweden.
Scientists have identified a protein that acts as a “master switch” in certain white blood cells and determines whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation. Inflammatory responses are an important defence […]
For most of us, the “placebo effect” is synonymous with the power of positive thinking; it works because you believe you are taking a real drug. But a new study rattles this assumption. Researchers at Harvard Medical School’s Osher Research Center and Beth Israel Deaconess Medical Center (BIDMC) have found that placebos work even when […]
Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a University at Buffalo behavioral scientist achieved significant relief within four weeks of beginning treatment. These patients, called “rapid responders” maintained their improvement at a three-month follow-up, despite reporting more severe IBS symptoms when they started the treatment.
Recent Comments